CLINICAL_TRIALS
trial_result
· 2013-02-20
Clinical Trial Update: Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung Disease [Phase 2]
Summary
Phase 2 trial evaluating lucinactant for mucus clearance in cystic fibrosis has completed and results are posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of North Carolina, Chapel Hill | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2013-02-20